PetMed Express, Inc., through its various subsidiaries, operates as a prominent pet pharmacy across the United States. The company provides a comprehensive range of both prescribed and over-the-counter animal medications, health-related items, and other essential supplies for canines, felines, and equines. Their non-pr…
An institutional-grade, numbers-driven thesis on PETS — generated on demand from live fundamentals, scores and forecast.
Member feature · 7-day free trial · no charge today · cancel anytime
As of July 4, 2026, TradersQuant's model rates PetMed Express, Inc. (PETS) 43/100 with a 12-month base-case forecast of $11.00 — +455.6% versus the current price of $1.98. PetMed Express, Inc. trades at $1.98 in the Healthcare sector, with a market capitalisation of $42.3M. The score blends valuation, growth, earnings quality and momentum into a single grade.
The 12-month analyst consensus price target for PETS is $11.00, implying +455.6% versus the current price. The model's 12-month scenario range runs from $0.85 (bear) to $1.37 (bull), with a base case of $1.10.
On the fundamentals, PetMed Express shows a P/E of -0.7, trailing revenue of $179.0M, revenue growth of -21.1% YoY. This page also tracks PETS's short interest, institutional (smart-money) positioning and the options market — the same cross-signal view institutions watch.
PETS currently carries a TradersQuant composite score of 43/100, which we read as a cautious signal. The Wall-Street analyst consensus is "Hold". Our 12-month price target of $11.00 implies +455.6% from $1.98. This is research, not financial advice — always combine it with your own judgement.
The analyst consensus price target for PETS is $11.00, about +455.6% versus the latest price of $1.98. Consensus is based on 10 analysts.
TradersQuant's 12-month model forecast for PETS is a base case of $1.10, ranging from $0.85 (bear) to $1.37 (bull), an expected return of -44.3%. Forecasts are model estimates, not guarantees.
The TradersQuant price prediction for PETS over the next 12 months is $1.10 in the base case (bear $0.85, bull $1.37), versus today's price of $1.98. Unlike black-box prediction sites, every TradersQuant call is logged at the price and date it was made and graded publicly against the S&P 500.
We deliberately don't publish 2030 price predictions for PETS — no model can honestly forecast a single stock five-plus years out, and sites that do are guessing. TradersQuant focuses on a rigorous 12-month bull/base/bear range, refreshed continuously and graded on our public track record.
TradersQuant estimates PETS's fair value at $11.00, implying +455.6% of expected upside versus the current price.
PetMed Express does not currently pay a dividend.
Data and model outputs are for research only and are not financial advice. Figures update continuously.
